Instituto Mexicano del Seguro v. Zimmer Biomet Holdings, Inc., No. 21-1224 (7th Cir. 2022)
Annotate this Case
In 2008-2013, IMSS, the agency of the Mexican government tasked with purchasing medical products for Mexican citizens, purchased medical products from Zimmer, a medical device company, headquartered in Indiana and incorporated in Delaware. Zimmer distributes its products in Mexico through an indirectly wholly-owned subsidiary. IMSS claims Zimmer orchestrated an international bribery scheme from its Indiana headquarters to facilitate the sale of unregistered medical products and paid around $1 million in bribes to its “Mexican agents” who passed bribes to Mexican government officials.
IMSS sued in the Northern District of Indiana, alleging two causes of action under Mexican law (breach of contract and violating the Law of Acquisitions, Leases and Services of the Public Sector) and fraud. for which the relief is the same under U.S. or Mexican law. The district court disagreed with IMSS’s interpretation of the United Nations Convention Against Corruption (UNCAC) and dismissed based on forum non conveniens. The Seventh Circuit affirmed. Two of IMSS’s claims arise under Mexican law and the remedy for the third is identical in either country. There is no risk IMSS will be deprived of a remedy by litigating in Mexican courts. The court noted the hardship of transporting witnesses from Mexico to the U.S. and that UNCAC is expressly non-self-executing.
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.